| Mechanism |
• Diclofenac – a non‑steroidal anti‑inflammatory drug (NSAID) that blocks COX‑1/COX‑2 and reduces prostaglandin synthesis.
• Methotrexate (MTX) – a disease‑modifying antirheumatic drug (DMARD) that inhibits dihydrofolate reductase, limiting DNA synthesis in rapidly dividing cells (including immune cells). |
| Common indication |
Both are used in rheumatoid arthritis (RA) and other inflammatory arthritides. MTX is usually the first‑line DMARD; diclofenac is added for extra pain and swelling control. |
| Key interaction |
NSAIDs can blunt renal clearance of MTX, especially at higher doses. This can raise MTX serum levels → ↑ risk of bone marrow suppression, hepatotoxicity, and mucositis. The interaction is more pronounced with systemic diclofenac than with topical preparations. |
| Clinical pearls |
1. Use the lowest effective NSAID dose and keep duration short (≤2–4 weeks when possible).
2. Check renal function (serum creatinine, eGFR) before starting combination therapy and periodically thereafter.
3. Monitor MTX levels (plasma MTX, if available) and blood counts (CBC), liver enzymes, and urinalysis.
4. Consider folic acid supplementation (usually 1 mg daily or 5 mg weekly) to mitigate MTX toxicity.
5. Avoid high‑dose or continuous NSAID use when MTX is at doses >15 mg/week.
6. Be vigilant for GI symptoms (bleeding, ulceration) because both drugs increase GI irritation. |
| Topical vs Oral |
Topical diclofenac (Voltaren® gel) delivers drug to the joint with minimal systemic absorption (<3 % of the oral dose). It’s generally safer to use concurrently with MTX, but still watch for local skin reactions. |
| Contraindications/Warnings |
• Severe renal impairment (eGFR < 30 mL/min/1.73 m²).
• Active peptic ulcer disease or significant GI bleeding risk.
• History of severe liver disease.
• Pregnant/breast‑feeding women (both drugs are teratogenic). |
| Side‑effect overlap |
• MTX: bone marrow suppression, hepatotoxicity, mucositis, pulmonary toxicity, nephrotoxicity.
• Diclofenac: GI bleeding, renal dysfunction, hypertension, increased cardiovascular risk.
When taken together, the risk of both GI bleeding and renal dysfunction is amplified. |
| Practical tips for patients |
1. Take MTX on an empty stomach with a full glass of water.
2. Take diclofenac after food to reduce GI upset.
3. Avoid alcohol (both drugs can increase liver strain).
4. Keep hydrated and monitor urine output.
5. Report any unusual symptoms (black stools, fatigue, fever, shortness of breath, jaundice, rash) immediately. |
| When to seek medical help |
• Fever > 38 °C (100.4 °F)
• Persistent nausea/vomiting
• Unexplained bruising or bleeding
• Dark urine or jaundice
• Shortness of breath or chest pain
• Any new or worsening rash |